This inventor holds 1 USPTO granted patent. Top assignee: Sekisui Kagaku Kogyo Kabushiki Kaisha. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Michiharu Ando: Innovator in Pharmaceutical Preparations
Introduction
Michiharu Ando is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical preparations, particularly in the development of innovative delivery systems.
Latest Patents
Ando holds a patent for a percutaneous pharmaceutical preparation. This invention is a percutaneous administration type pharmaceutical preparation in tape form. It comprises a flexible backing that is not permeable by the active ingredient and an adhesive base layer formed on the flexible backing. The adhesive base layer consists essentially of an adhesive base material and an active ingredient compatible with the adhesive base material. The adhesive base material is a copolymer containing 2-ethylhexyl acrylate (EHA) in a concentration of 45 mole% or more and N-vinyl-2-pyrrolidone (VP) in a concentration of 20 to 55 mole%. The active ingredient is isosorbide dinitrate (ISDN), which is contained in a concentration of 10% by weight or more in the adhesive base material.
Career Highlights
Ando is associated with Sekisui Kagaku Kogyo Kabushiki Kaisha, a company known for its advancements in chemical and pharmaceutical technologies. His work has contributed to the development of effective drug delivery systems that enhance patient compliance and therapeutic outcomes.
Collaborations
Ando has collaborated with notable colleagues, including Mutsumi Fukuda and Takashi Nakagawa. Their combined expertise has fostered innovation in the pharmaceutical field.
Conclusion
Michiharu Ando's contributions to pharmaceutical preparations exemplify the importance of innovation in healthcare. His patent for a percutaneous pharmaceutical preparation showcases his commitment to improving drug delivery methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile